Vol. 5 (09) pp. 443-449 DOI: 10.21474/IJAR01/5348

Otitis Media

and
11 Downloads 96 Views
Crossref

Download Full Paper (PDF)

Abstract

Acute otitis media and otitis media with effusion are common childhood disorders, a source of significant morbidity, and a leading cause of antibiotic prescription in primary health care. Although effective treatments are available, some shortcomings remain, and thus better treatments would be welcome. Recent discoveries within the field of otitis media research relating to its etiology and pathogenesis have led to further investigation aimed at developing novel treatments. This article provides a review of the latest evidence relating to the understanding of acute otitis media and otitis media with effusion, current treatment strategies, their limitations, new areas of research, and novel strategies for treatment.Middle ear infection (otitis media)

Article Analytics

References

  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075145/
  2. Rosenfeld RM, Schwartz SR, Pynnonen MA, et al. Clinical Practice Guideline: Tympanostomy Tubes in Children. Otolaryngology -- Head and Neck Surgery. 2013;149:S1?S35. [PubMed]
  3. Teele DWKJ, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989;160:83?94. [PubMed]
  4. Derkay CS. Pediatric otolaryngology procedures in the United States: 1977-1987. Int J Pediatr Otorhinolaryngol. 1993;25:1?12. [PubMed]
  5. Kogan MD, Overpeck MD, Hoffman HJ, Casselbrant ML. Factors associated with tympanostomy tube insertion among preschool-aged children in the United States. Am J Public Health. 2000;90:245?50. [PMC free article] [PubMed]
  6. Boston M, McCook J, Burke B, Derkay C. Incidence of and risk factors for additional tympanostomy tube insertion in children. Arch Otolaryngol Head Neck S
  7. Vergison A, Dagan R, Arguedas A, et al. Otitis media and its consequences: beyond the earache. Lancet Infect Dis. 2010;10:195?203. [PubMed]
  8. Cripps AW, Otczyk DC. Prospects for a vaccine against otitis media. Expert Rev Vaccines. 2006;5:517?34. [PubMed]
  9. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403?9. [PubMed]
  10. Prymula R, Peeters P, Chrobok V, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367:740?8. [PubMed]
  11. Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J. 2004;23:1142?52. [PubMed]
  12. Centers for Disease Control and Prevention. Progress in introduction of pneumococcal conjugate vaccine?worldwide, 2000?2008. MMWR Morb Mortal Wkly Rep. 2008;57:1148?51. [PubMed]
  13. Vesikari T, Wysocki J, Chevallier B, et al. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J. 2009;28:S66?76. [PubMed]
  14. Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics. 2010;125:866?75. [PubMed]
  15. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19:187?95. [PubMed]

How to Cite This Article

Zainahalqahtani And Aisha Nasser ALQahtani (2017); Otitis Media, Int. J. of Adv. Res., 5 (09), 443-449, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/5348

Corresponding Author

Zainahalqahtani

Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.